MedTrace Logo

Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

NCT04100824 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-06-13

No results posted yet for this study

Summary

Aim of work:

To evaluate the effect of stellate ganglion block in prevention of cerebrovascular spasm in traumatic subarachnoid hemorrhage Primary outcome: Asses changes of cerebral blood flow velocity by Trans cranial Doppler.

Secondary outcome: Asses changes in clinical status

Conditions

  • Subarachnoid Hemorrhage

Interventions

PROCEDURE

stellate ganglion block by transcranial doppler

stellate ganglion block is a block of sympathetic ganglion

DRUG

Nimodipine

Nimodipine 60mg every 4h

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-11
Primary Completion
2022-12-11
Completion
2023-01-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04100824 on ClinicalTrials.gov